Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MDCK CELL LINE ADAPTED TO SERUM-FREE CULTURE AND SUSPENSION CULTURE, AND METHOD FOR PREPARING VIRUSES FOR VACCINE USING CELLS THEREOF
Document Type and Number:
WIPO Patent Application WO/2012/033236
Kind Code:
A1
Abstract:
The present invention relates to an MDCK cell line which is derived from a MDCK cell deposited as an ATCC CCL-34 cell line and can be cultured without serum and can be suspension cultured, and preferably, to cell lines MDCK S1023, MDCK S10234, and MDCK S3851. In addition, the present invention relates to a culture method for growing the MDCK cell, and a method for preparing viruses for vaccines using the MDCK cell.

Inventors:
PARK YONG WOOK (KR)
LEE KUN SE (KR)
LEE BONG-YONG (KR)
PARK MAHN HOON (KR)
KIM HUN (KR)
KIM YUN-HEE (KR)
LEE SU-JEEN (KR)
Application Number:
PCT/KR2010/006041
Publication Date:
March 15, 2012
Filing Date:
September 06, 2010
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SK CHEMICALS CO LTD (KR)
PARK YONG WOOK (KR)
LEE KUN SE (KR)
LEE BONG-YONG (KR)
PARK MAHN HOON (KR)
KIM HUN (KR)
KIM YUN-HEE (KR)
LEE SU-JEEN (KR)
International Classes:
C12N5/071; A61K39/12; A61K39/145; C12N5/02; C12N7/01
Foreign References:
US6825036B22004-11-30
Other References:
SAFC BIOSCIENCES: "Suspension MDCK Cell Culture in EX-CELL (TM) MDCK Serum- Free Medium", TECHNICAL BULLETIN, 31 March 2006 (2006-03-31)
CHU, C. ET AL.: "Conversion of MDCK cell line to suspension culture by transfecting with human siat7e gene and its application for influenza virus production", PNAS, vol. 106, no. 35, 1 September 2009 (2009-09-01), pages 14802 - 14807
GEORGE, M. ET AL.: "Production of Cell Culture (MDCK) Derived Live Attenuated Influenza Vaccine (LAFV) in a Fully Disposable Platform Process", BIOTECHNOLOGY AND BIOENGINEERING, vol. 106, no. 6, 15 August 2010 (2010-08-15), pages 906 - 917
Attorney, Agent or Firm:
PHIL & ONZI INT'L PATENT & LAW FIRM (KR)
특허법인 필앤온지 (KR)
Download PDF:
Claims: